Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
about
Clinical application of bioartificial liver support systemsLiver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failureProspective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.Bioartificial liver support devices: historical perspectives.The development of a new bioartificial liver and its application in 12 acute liver failure patients.Evaluation of liver support systems for preclinical testing by animal trials.Functional cells cultured on microcarriers for use in regenerative medicine research.Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.Construction of IL-2 gene-modified human hepatocyte and its cultivation with microcarrier.Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system.Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration.Hepatocyte-like cells from directed differentiation of mouse bone marrow cells in vitro.Decellularization of Liver and Organogenesis in Rats.Reversal of experimental posthepatectomy liver failure in pigs: a new application of hepatocyte bioreactors.A novel plasma filtration therapy for hepatic failure: preclinical studies.
P2860
Q24540124-033509F8-3582-4536-AE2E-C8398D5E2FEDQ28480510-6F592D59-C42C-4274-BD4F-B72E231CC2B8Q34313335-B99DA30B-6DFE-496B-885E-A15EB5006DEDQ35212310-3B103469-A4AF-4550-8955-33B53E72FFE8Q36178720-2560BA9C-9988-4CB1-B359-C5E0526B2588Q36616615-A70AFCEC-7D9B-4F6C-B851-52E346C12C16Q37795961-81855CC5-B8BA-4096-8ADF-103C0C5D33DFQ38264625-151D41DA-2F7F-4CD2-AA3B-3A7D04A7F6CDQ42695574-A3DF1E1E-EB6B-4375-ACDB-A374C2155ECEQ43136889-1BC435C8-88C5-4B31-92C8-57BAEA9AB166Q44130875-DBD7C6A0-4D66-48B8-A109-58F01F085203Q46393511-E9B95513-B883-48E9-B108-3F0756C33769Q47794359-923F7F7B-B147-418B-96DD-2C87A4261FFCQ48134141-90A1FF4E-DBEA-450C-8822-F4EE19694331Q48549126-440D3AEE-0205-4BB7-ADC0-DEA4DCB07B83
P2860
Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Bioartificial liver treatment ...... ociated transcription factors.
@en
type
label
Bioartificial liver treatment ...... ociated transcription factors.
@en
prefLabel
Bioartificial liver treatment ...... ociated transcription factors.
@en
P2093
P356
P1476
Bioartificial liver treatment ...... ociated transcription factors.
@en
P2093
Arkadopoulos N
Demetriou AA
Kamohara Y
P304
P356
10.1006/JSRE.1999.5669
P577
1999-08-01T00:00:00Z